The Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance

This study has been completed.
Sponsor:
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00129636
First received: August 11, 2005
Last updated: September 22, 2005
Last verified: August 2005
  Purpose

As part of the NHS plan it has been proposed to extend some consultants' usual practices and to send all patients copies of the letters sent to their general practitioners (GPs) following outpatient consultations. The current Secretary of State for Health has further extended this proposal and suggested that patients should have a specific letter to themselves after a hospital consultation.

The aim of this study is to send patients both a copy of the letter sent to their GPs and a specific letter to themselves and to assess the usefulness and comprehensibility of each.


Condition Intervention
Heart Diseases
Lung Diseases
Procedure: Additional specific letter written to patient

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Educational/Counseling/Training
Official Title: A Study to Determine the Usefulness of Patients Receiving Their Own Letter After an Outpatient Attendance Compared to Receiving a Copy of the Letter Being Sent to Their General Practitioner

Further study details as provided by Imperial College London:

Primary Outcome Measures:
  • Comprehensibility of the two styles of letter (length, reading ease, Flesch Kincaid Grade, items misunderstood)

Secondary Outcome Measures:
  • GP and patient preference for one or both letters
  • Deficiencies in the patient letter
  • Patient Enablement Questionnaire

Estimated Enrollment: 150
Study Start Date: March 2004
Estimated Study Completion Date: July 2005
Detailed Description:

As part of the NHS plan it has been proposed to extend some consultants' usual practices and to send all patients copies of the letters sent to their general practitioners following outpatient consultations. The current Secretary of State for Health has further extended this proposal and suggested that patients should have a specific letter to themselves after a hospital consultation.

The aim of this study is to send patients both a copy of the letter sent to their GPs and a specific letter to themselves and to assess the usefulness and comprehensibility of each. This study will assess the two styles of letter in Cardiology and Respiratory Outpatient Clinics staffed by 7 consultants and will involve a group of 15-20 patients from each of the clinics, total number approximately 150 patients.

All patients attending the clinics will be given a sheet outlining the study before their consultations. If they are interested in the study, patients will be given a Patient Information Sheet and asked consent to take part. The length of each of the two dictated letters will be recorded. To avoid costs to the NHS, the direct to patient letters will be typed at the study investigators' cost. Two copies of each letter, a short explanatory letter and a questionnaire will be sent to the patient and the patient will be asked to circle points in each of the letters which are unclear and return them to the department. At the end of the study the general practitioners will be contacted and asked their views about the two letters.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All patients attending respiratory/cardiology outpatient clinics

Exclusion Criteria:

  • Patients with reading/language difficulties
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00129636

Locations
United Kingdom
NHLI Imperial College
London, United Kingdom, W6 8RF
Sponsors and Collaborators
Imperial College London
Investigators
Principal Investigator: Martyn R Partridge, MD FRCP Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00129636     History of Changes
Other Study ID Numbers: NHLICX3762
Study First Received: August 11, 2005
Last Updated: September 22, 2005
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Heart Diseases
Lung Diseases
Cardiovascular Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 20, 2014